The 2009 H1N1 flu pandemic in Navarre
DOI:
https://doi.org/10.23938/ASSN.0556Keywords:
Gripe. Pandemia. Salud pública. Vigilancia epidemiológica.Abstract
Background. To describe flu activity during the 2009-2010 pandemic in Navarre and compare it to previous seasons. Methods. An analysis was made of all flu cases reported in primary care and all the virological confirmations made in patients in primary care and in hospitals of Navarre between week 21 of 2009 and week 20 of 2010. Results. Influenza A (H1N1) Virus 2009 was detected in Navarre between week 23 of 2009 and week 2 of 2010, a period when 39 medically diagnosed cases of flu syndrome per 1,000 inhabitants were registered. The epidemic threshold was surpassed in two periods, with a peak in July and a greater one in November. The greatest incidence was reached in children aged between 5 and 14 years (121 per thousand), followed by the group of under fives. There were 224 hospitalisations (36 per 100,000 inhabitants) with confirmation of Influenza A (H1N1) Virus 2009, 8% of whom required admission to intensive care units and there were four deaths (0.6 per 100,000 inhabitants). The rate of hospitalisation was greater amongst children under five (163 per 100,000 inhabitants), while the probability of referral to intensive care increased with age. Conclusion. In spite of not having a specific vaccine available until the season was very well advanced, Influenza A (H1N1)Virus 2009 produced a flu wave with similar levels to those of other seasons and its repercussion in hospitalisations and serious cases was moderate.Downloads
References
1. GLEZEN WP. Serious morbidity and mortality associated with influenza epidemics. Epidemiol Rev 1982; 4: 25-44.
https://doi.org/10.1093/oxfordjournals.epirev.a036250
2. THOMPSON WW, SHAY DK, WEINTRAUB E, BRAMMER L, COX N, ANDERSON LJ et al. Mortality associated with influenza and respiratory syncytial virus in the United States. JAMA 2003; 289: 179-186.
https://doi.org/10.1001/jama.289.2.179
3. THOMPSON WW, SHAY DK, WEINTRAUB E, BRAMMER L, BRIDGES CB, COX NJ et al. Influenza-associated hospitalizations in the United States. JAMA 2004; 292: 1333-1340.
https://doi.org/10.1001/jama.292.11.1333
4. NICHOLSON KG, WOOD JM, ZAMBON M. Influenza. Lancet 2003; 362: 1733-1745.
https://doi.org/10.1016/S0140-6736(03)14854-4
5. REICHERT TA, SIMONSEN L, SHARMA A, PARDO SA, FEDSON DS, MILLER MA. Influenza and the winter increase in mortality in the United States, 1959-1999. Am J Epidemiol 2004; 160: 492-502.
https://doi.org/10.1093/aje/kwh227
6. FIORE AE, SHAY DK, BRODER K, ISKANDER JK, UYEKI TM, MOOTREY G et al. Prevention and control of seasonal influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP) 2009. MMWR Recomm Rep 2009; 58: 1-52.
7. New influenza A/H1N1 virus: global epidemiological situation, June 2009. Wkly Epidemiol Rec 2009; 84: 249-257.
8. Novel Swine-Origin Influenza A (H1N1) Virus Investigation Team. Emergence of a novel swine-origin influenza A (H1N1) virus in humans. N Engl J Med 2009; 360: 2605-2615.
https://doi.org/10.1056/NEJMoa0903810
9. ECHEVERRÍA-ZUNO S, MEJÍA-ARANGURÉ JM, MAR-OBESO AJ, GRAJALES-MUÑIZ C, ROBLES-PÉREZ E, GONZÁLEZ-LEÓN P et al. Infection and death from influenza A H1N1 virus in Mexico: a retrospective analysis. Lancet 2009; 374: 2072-2079.
https://doi.org/10.1016/S0140-6736(09)61638-X
10. GARTEN RJ, DAVIS CT, RUSSELL CA, SHU B, LINDSTROM S, BALISH A et al. Antigenic and genetic characteristics of swine-origin 2009 A (H1N1) influenza viruses circulating in humans. Science 2009; 325: 197-201.
https://doi.org/10.1126/science.1176225
11. ICPC-2. International Classification of Primary Care, 2nd edn. Oxford: Oxford University Press, 1998.
12. LESSLER J, REICH NG, Cummings DAT and the New York City Department of Health and Mengal Hygiene Swine Influenza Investigation Team. Outbreak of 2009 pandemic influenza A (H1N1) at a New York city school. N Engl J Med 2009; 361: 2628-2636.
https://doi.org/10.1056/NEJMoa0906089
13. ZHAO H, JOSEPH C, PHIN N. Outbreaks of influenza and influenza-like illness in schools in England and Wales, 2005/06. Euro Surveill. 2007 May 1; 12 (5): E3-4.
https://doi.org/10.2807/esm.12.05.00705-en
14. LARRAURI CÁMARA A, JIMÉNEZ-JORGE S, SIMON MÉNDEZ L, DE MATEO ONTAÑÓN S, en representación del Sistema de Vigilancia de Gripe en España (SVGE). Vigilancia de la pandemia de gripe (H1N1) 2009 en España. Rev Esp Salud Pública 2010; 84; 569-588.
https://doi.org/10.1590/S1135-57272010000500009
15. HANCOCK K, VEGUILLA V, LU X, ZHOG W, BUTLER EN, SUN H et al. Cross-reactive antibody responses to the 2009 pandemic H1N1 influenza virus. N Engl J Med 2009; 361: 1945-1962.
https://doi.org/10.1056/NEJMoa0906453
16. CASTILLA J, ARREGUI L, BALEZTENA J, BARRICARTE A, BRUGOS A, CARPINTERO M et al. Incidencia de la gripe y efectividad de la vacuna antigripal en la temporada 204-2005. An Sist Sanit Navar 2006; 29: 83-92.
https://doi.org/10.4321/S1137-66272006000100008
17. The ANZIC influenza Investigators. Critical care services and 2009 H1N1 influenza in Australia and New Zealand. N Engl J Med 2009; 361: 1925-1934.
https://doi.org/10.1056/NEJMoa0908481
18. CASTILLA J, ETXEBERRIA J, ARDANAZ E, FLORISTÁN Y, LÓPEZ ESCUDERO R, GUEVARA M. Estimating the impact of the 2009 influenza A(H1N1) pandemic on mortality in the elderly in Navarre, Spain. Euro Survell 2010; 15 (5) pii=19481.
https://doi.org/10.2807/ese.15.05.19481-en
19. KELLY H, GRANT K. Interim analysis of pandemic influenza (H1N1) 2009 in Australia: surveillance trends, age of infection and effectiveness of seasonal vaccination. Euro Surveill 2009; 14: 150-154.
https://doi.org/10.2807/ese.14.31.19288-en
20. Centers for Disease Control and Prevention. Effectiveness of 2009-09 trivalent influenza vaccine against 2009 pandemic influenza A (H1N1)-United States, May-June 2009. MMWR 2009; 58: 1241-1245.
21. GARCÍA-GARCÍA L, VALDESPINO-GÓMEZ JL, LAZCANO-PONCE E, JIMÉNEZ-CORONA A, HIGUERA-IGLESIAS A, CRUZ-HERVENT P et al. Partial protection of seasonal trivalent inactivated vaccine against novel pandemic influenza A/H1N1 2009: case-control study in Mexico City. BMJ 2009; 339: b3928.
https://doi.org/10.1136/bmj.b3928
22. SKOWRONSKI DM, DE SERRES G, CROWCROFT NS, JANJUA NZ, BOULIANNE N et al. Association between the 2008-09 Seasonal Influenza Vaccine and Pandemic H1N1 Illness during Spring-Summer 2009: Four Observational Studies from Canada. PLoS Med 2010; 7(4): e1000258. doi:10.1371/journal.pmed.1000258
https://doi.org/10.1371/journal.pmed.1000258
23. JOHANSEN K, NICOLL A, CIANCIO BC, KRAMARZ P. Pandemic influenza A(H1N1) 2009 vaccines in the European Union. Euro Surveill 2009; 14: 245-251.
https://doi.org/10.2807/ese.14.41.19361-en
24. World Health Organization. Mathematical modelling of the pandemic H1N1 2009. Wkly Epidemiol Rec 2009; 84: 341-348.
25. World Health Organization. Recommended virus for influenza vaccines for use in the 2010-2011 northern hemisphere influenza. Wkly Epidemiol Rec 2010; 85: 81-92.
Downloads
Published
How to Cite
Issue
Section
License
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
La revista Anales del Sistema Sanitario de Navarra es publicada por el Departamento de Salud del Gobierno de Navarra (España), quien conserva los derechos patrimoniales (copyright ) sobre el artículo publicado y favorece y permite la difusión del mismo bajo licencia Creative Commons Reconocimiento-CompartirIgual 4.0 Internacional (CC BY-SA 4.0). Esta licencia permite copiar, usar, difundir, transmitir y exponer públicamente el artículo, siempre que siempre que se cite la autoría y la publicación inicial en Anales del Sistema Sanitario de Navarra, y se distinga la existencia de esta licencia de uso.
